Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Changes in thrombocyte aggregation in primary hypothyroidism]

I Lazúrová1, J Lazúr, M Mosanská

  • 1II. interná klinika FNsP, LF UPJS Kosice.

Vnitrni Lekarstvi
|September 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bioactive compounds from Psilocybe cubensis mycelial cultures with transient anxiolytic effects in mice.

Journal of physiology and pharmacology : an official journal of the Polish Physiological Society·2026
Same author

Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration.

Journal of endocrinological investigation·2024
Same author

Is Apelin a new biomarker in patients with polycystic ovary syndrome?

Physiological research·2022
Same author

The Association Between Three Adipocytokines (Adiponectin, Resistin and Visfatin) And Thyroid Status in Patients With Type 2 Diabetes Mellitus and Autoimmune Thyroiditis.

Physiological research·2021
Same author

Insulin-like growth factor (IGF) system and hormonal-metabolic profile in women with polycystic ovary syndrome.

Bratislavske lekarske listy·2021
Same author

Is there a role for the IGF system and epidermal growth factor (EGF) in the pathogenesis of adrenocortical adenomas? A preliminary case-control study.

Physiological research·2020

Primary hypothyroidism impairs platelet aggregation, a condition that often improves with levothyroxine treatment. However, some patients may experience persistent thrombocytopathy even after treatment.

Area of Science:

  • Endocrinology
  • Hematology

Context:

  • Primary hypothyroidism is associated with various hemostatic abnormalities.
  • Platelet dysfunction can contribute to bleeding risks in hypothyroid patients.

Purpose:

  • To investigate the effect of primary hypothyroidism on platelet aggregation.
  • To evaluate the impact of levothyroxine substitution therapy on platelet function in hypothyroid patients.

Summary:

  • This study assessed platelet aggregation in 17 primary hypothyroidism patients and 10 controls.
  • Untreated hypothyroid patients showed significantly reduced platelet aggregation in response to adrenaline and ADP compared to controls.
  • Platelet aggregation improved in 63% of patients after 2 months of levothyroxine treatment, though some persistent dysfunction was noted.

Related Experiment Videos

Impact:

  • Impaired platelet aggregation is a common finding in primary hypothyroidism.
  • Levothyroxine treatment can partially restore platelet function, suggesting a link between thyroid hormones and hemostasis.
  • Understanding these effects is crucial for managing bleeding risks and drug interactions in hypothyroid patients.